Biovie Inc. SEC filings BIVIW

Biovie Inc. has 507 filings in SEC EDGAR's recent list, going back to Jul 2, 2013. Its latest annual report, Form 10-K, was filed on Aug 13, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 11, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (material agreement). The company's fiscal year ends on June 30.

Biovie Inc. SEC filings
Form Description Filed Period
8-K Current report
Material agreement
Sep 14, 2026 Sep 11, 2026
8-K Current report
Regulation FD disclosure
Aug 6, 2026 Aug 6, 2026
8-K Current report
Officer or director change
Nov 13, 2025 Nov 10, 2025
8-K Current report
Shareholder vote results
Nov 12, 2025 Nov 10, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Aug 11, 2025 Aug 7, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 23, 2025 Jul 17, 2025
8-K Current report
Change to shareholder rights
Jun 27, 2025 Jun 26, 2025
8-K Current report
Shareholder vote results
Jun 24, 2025 Jun 23, 2025
8-K Current report
Officer or director change
Mar 28, 2025 Mar 28, 2025
8-K Current report
Shareholder vote results
Nov 8, 2024 Nov 7, 2024
8-K Current report
Regulation FD disclosure, Other events
Oct 29, 2024 Oct 28, 2024
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Oct 29, 2024 Oct 28, 2024
8-K Current report
Regulation FD disclosure, Other events
Oct 24, 2024 Oct 23, 2024
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Oct 24, 2024 Oct 23, 2024
8-K Current report
Regulation FD disclosure, Other events
Oct 22, 2024 Oct 22, 2024
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Oct 22, 2024 Oct 21, 2024
8-K Current report
Regulation FD disclosure, Other events
Sep 25, 2024 Sep 25, 2024
8-K/A Amended current report Sep 24, 2024 Sep 23, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Sep 24, 2024 Sep 23, 2024
8-K Current report
Other events
Aug 21, 2024 Aug 20, 2024
8-K/A Amended current report
Change to shareholder rights, Bylaw or fiscal year change
Aug 6, 2024 Aug 1, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
Aug 1, 2024 Jul 29, 2024
8-K Current report
Officer or director change
Jul 30, 2024 Jul 25, 2024
8-K Current report
Listing notice
Apr 19, 2024 Apr 18, 2024
8-K Current report
Other events
Mar 11, 2024 Mar 11, 2024
8-K Current report
Regulation FD disclosure, Other events
Mar 6, 2024 Mar 6, 2024
8-K/A Amended current report Mar 4, 2024 Mar 4, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Mar 4, 2024 Mar 4, 2024
8-K Current report
Other events
Mar 1, 2024 Mar 1, 2024
8-K Current report
Other events
Jan 25, 2024 Jan 19, 2024
8-K Current report
Other events
Jan 19, 2024 Jan 19, 2024
8-K Current report
Other events
Nov 29, 2023 Nov 29, 2023
8-K Current report
Shareholder vote results
Nov 13, 2023 Nov 8, 2023
8-K Current report
Other events
Oct 25, 2023 Oct 25, 2023
8-K Current report
Regulation FD disclosure
Sep 11, 2023 Sep 8, 2023
8-K Current report
Other events
Apr 7, 2023 Apr 6, 2023
8-K Current report
Regulation FD disclosure
Mar 23, 2023 Mar 23, 2023
8-K Current report
Bylaw or fiscal year change
Mar 13, 2023 Mar 12, 2023
8-K Current report
Officer or director change
Mar 6, 2023 Mar 2, 2023
8-K Current report
Other events
Dec 23, 2022 Dec 23, 2022
8-K Current report
Other events
Dec 15, 2022 Dec 14, 2022
8-K Current report
Regulation FD disclosure
Dec 7, 2022 Dec 7, 2022
8-K Current report
Regulation FD disclosure, Other events
Dec 6, 2022 Dec 5, 2022
8-K Current report
Other events
Dec 6, 2022 Dec 6, 2022
8-K Current report
Shareholder vote results
Nov 10, 2022 Nov 9, 2022
8-K Current report
Other events
Oct 5, 2022 Oct 4, 2022
8-K/A Amended current report
Regulation FD disclosure, Other events
Sep 7, 2022 Sep 7, 2022
8-K Current report
Regulation FD disclosure, Other events
Sep 7, 2022 Sep 7, 2022
8-K Current report
Material agreement
Aug 31, 2022 Aug 31, 2022
8-K/A Amended current report
Material agreement, Unregistered share sale
Jul 18, 2022 Jul 15, 2022
8-K Current report
Material agreement, Unregistered share sale
Jul 15, 2022 Jul 15, 2022
8-K Current report
New debt, Regulation FD disclosure
Jun 29, 2022 Jun 28, 2022
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Dec 1, 2021 Nov 30, 2021
8-K Current report
Shareholder vote results
Oct 14, 2021 Oct 13, 2021
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Aug 11, 2021 Aug 8, 2021
8-K Current report
Regulation FD disclosure
Aug 5, 2021 Aug 5, 2021
8-K Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
Jun 11, 2021 Jun 10, 2021
8-K Current report
Regulation FD disclosure
May 17, 2021 May 17, 2021
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
May 10, 2021 May 9, 2021
8-K Current report
Regulation FD disclosure
Apr 29, 2021 Apr 28, 2021
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
Apr 27, 2021 Apr 27, 2021
8-K Current report
Unregistered share sale
Sep 23, 2020 Sep 23, 2020
8-K Current report
Officer or director change
Jun 22, 2020 Jun 16, 2020
8-K Current report
Other events
Nov 15, 2019 Nov 13, 2019
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights
Oct 9, 2019 Oct 9, 2019
8-K Current report
Material agreement, New debt, Unregistered share sale, Change to shareholder rights
Sep 25, 2019 Sep 24, 2019
8-K Current report
Other events
Aug 14, 2019 Aug 12, 2019
8-K Current report
Other events
Jun 28, 2019 Jun 26, 2019
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Officer or director change
Jun 28, 2019 Jun 24, 2019
8-K Current report
Auditor change
Jan 28, 2019 Jan 18, 2019
8-K Current report
Acquisition or sale of assets
Dec 31, 2018 Dec 24, 2018
8-K Current report
Other events
Nov 29, 2018 Nov 28, 2018
8-K Current report
Officer or director change
Nov 1, 2018 Nov 1, 2018
8-K Current report
Officer or director change, Other events
Oct 9, 2018 Oct 1, 2018
8-K Current report
Change in control, Bylaw or fiscal year change
Aug 16, 2018 Aug 13, 2018
8-K Current report
Material agreement, New debt, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change
Jul 3, 2018 Jul 2, 2018
8-K/A Amended current report
New debt
May 30, 2018 May 21, 2018
8-K Current report
New debt
May 25, 2018 May 21, 2018
8-K Current report
New debt
Apr 30, 2018 Apr 25, 2018
8-K Current report
Auditor change
Mar 21, 2018 Mar 20, 2018
8-K Current report
Auditor change
Mar 9, 2018 Mar 5, 2018
8-K Current report
Officer or director change
Nov 7, 2017 Nov 2, 2017
8-K Current report
Officer or director change
Oct 30, 2017 Oct 25, 2017
8-K Current report
Officer or director change
Sep 28, 2017 Sep 24, 2017
8-K Current report
Other events
Jun 23, 2017 Jun 22, 2017
8-K Current report
Officer or director change
May 16, 2017 May 10, 2017
8-K Current report
New debt
Apr 10, 2017 Apr 7, 2017
8-K Current report
Other events
Apr 3, 2017 Apr 3, 2017
8-K/A Amended current report
Officer or director change
Mar 29, 2017 Mar 14, 2017
8-K Current report
Officer or director change
Mar 27, 2017 Mar 24, 2017
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jan 5, 2017 Jan 4, 2016
8-K Current report
Officer or director change, Other events
Dec 27, 2016 Dec 27, 2016
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jul 22, 2016 Jul 18, 2016
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change in control, Officer or director change, Bylaw or fiscal year change
Apr 15, 2016 Apr 11, 2016
8-K Current report
Auditor change
Aug 28, 2014 Aug 25, 2014

Showing 95 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BIVI (Nasdaq), BIVIW (Nasdaq)
Fiscal year ends
June 30
Incorporated in
NV
Headquarters
Carson City, NV
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1580149
Former names
NANOANTIBIOTICS, INC. (until Jul 22, 2016)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.